Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure syndrome with predisposition to developing leukemia. We found that multiple independent somatic hematopoietic clones arise early in life, most commonly harboring heterozygous mutations in EIF6 or TP53. EIF6 mutations cause functional compensation for the germline deficiency by alleviating the SDS ribosome joining defect, improving translation, and reducing p53 activation. TP53 mutations decrease checkpoint activation without affecting ribosome assembly. We link development of leukemia with acquisition of biallelic TP53 alterations. Our results define distinct pathways of clonal selection driven by germline fitness constraint and provide a mechanistic framework for clinical surveillance.

[1]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[2]  M. Norkin,et al.  Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study. , 2019, The Lancet. Haematology.

[3]  Donna Neuberg,et al.  A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies , 2019, Science.

[4]  F. Dimaio,et al.  Efficient consideration of coordinated water molecules improves computational protein-protein and protein-ligand docking , 2019, bioRxiv.

[5]  Ryan L. Collins,et al.  Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes , 2019, bioRxiv.

[6]  F. Camargo,et al.  Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis , 2018, Cell reports.

[7]  K. Myers,et al.  Diagnosis, Treatment, and Molecular Pathology of Shwachman-Diamond Syndrome. , 2018, Hematology/oncology clinics of North America.

[8]  A. Sakurada,et al.  A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  Markus Heinonen,et al.  Flex ddG: Rosetta ensemble-based estimation of changes in protein-protein binding affinity upon mutation , 2017, bioRxiv.

[10]  Christopher A. Miller,et al.  Somatic mutations and clonal hematopoiesis in congenital neutropenia. , 2018, Blood.

[11]  A. Warren Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome , 2017, Advances in biological regulation.

[12]  A. Schambach,et al.  An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries. , 2017, Biomaterials.

[13]  A. Shimamura,et al.  Germline Genetic Predisposition to Hematologic Malignancy. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  D. Neuberg,et al.  Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation , 2017, The New England journal of medicine.

[15]  Nicola D. Roberts,et al.  Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.

[16]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[17]  Itay Mayrose,et al.  ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules , 2016, Nucleic Acids Res..

[18]  Li Jin,et al.  Mechanism of eIF6 release from the nascent 60S ribosomal subunit , 2015, Nature Structural &Molecular Biology.

[19]  Matthew C. Canver,et al.  miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  D. Neuberg,et al.  Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. , 2015, Blood.

[21]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[22]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[23]  S. Volarevic,et al.  Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis. , 2014, Biochimica et biophysica acta.

[24]  David Baker,et al.  High-resolution comparative modeling with RosettaCM. , 2013, Structure.

[25]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[26]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[27]  Robert Gentleman,et al.  Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.

[28]  T. Leblanc,et al.  Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome , 2012, Haematologica.

[29]  J. Rommens,et al.  Deficiency of Sbds in the mouse pancreas leads to features of Shwachman-Diamond syndrome, with loss of zymogen granules. , 2012, Gastroenterology.

[30]  G. Montalbano,et al.  Deletion of chromosome 20 in bone marrow of patients with Shwachman‐Diamond syndrome, loss of the EIF6 gene and benign prognosis , 2012, British journal of haematology.

[31]  J. Rommens,et al.  Draft consensus guidelines for diagnosis and treatment of Shwachman‐Diamond syndrome , 2011, Annals of the New York Academy of Sciences.

[32]  R. Kay,et al.  Defective ribosome assembly in Shwachman-Diamond syndrome. , 2011, Blood.

[33]  Thomas M Green,et al.  A public genome-scale lentiviral expression library of human ORFs , 2011, Nature Methods.

[34]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[35]  D. Baker,et al.  Alternate states of proteins revealed by detailed energy landscape mapping. , 2011, Journal of molecular biology.

[36]  S. Gallo,et al.  Tagging of functional ribosomes in living cells by HaloTag® technology , 2011, In Vitro Cellular & Developmental Biology - Animal.

[37]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[38]  B. Ebert,et al.  Ribosomopathies: human disorders of ribosome dysfunction. , 2010, Blood.

[39]  M. Topf,et al.  Mechanism of eIF6-mediated Inhibition of Ribosomal Subunit Joining* , 2010, The Journal of Biological Chemistry.

[40]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[41]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[42]  Oliver F. Lange,et al.  Structure prediction for CASP8 with all‐atom refinement using Rosetta , 2009, Proteins.

[43]  S A Forbes,et al.  The Catalogue of Somatic Mutations in Cancer (COSMIC) , 2008, Current protocols in human genetics.

[44]  Akiko Shimamura,et al.  Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. , 2008, The Journal of clinical investigation.

[45]  Akiko Shimamura,et al.  The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. , 2007, Blood.

[46]  Michael Costanzo,et al.  The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast , 2007, Nature Genetics.

[47]  T. Tsuruta,et al.  Myeloid lineage‐selective growth of revertant cells in Fanconi anaemia , 2006, British journal of haematology.

[48]  R. Leary,et al.  The Shwachman-Diamond SBDS protein localizes to the nucleolus. , 2005, Blood.

[49]  C. Gorrini,et al.  Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly , 2003, Nature.

[50]  Johanna M. Rommens,et al.  Mutations in SBDS are associated with Shwachman–Diamond syndrome , 2003, Nature Genetics.

[51]  D. Malkin,et al.  Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study. , 2002, Experimental Hematology.

[52]  B. Alter,et al.  p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. , 2002, Archives of pathology & laboratory medicine.

[53]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[54]  M. Freedman,et al.  Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. , 2001, Blood.

[55]  J. Wagner,et al.  Somatic mosaicism in Fanconi anemia: Evidence of genotypic reversion in lymphohematopoietic stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Stephen K. Burley,et al.  Crystal structures of ribosome anti-association factor IF6 , 2000, Nature Structural Biology.

[57]  C. Mathew,et al.  Somatic Mosaicism in Fanconi Anemia: Molecular Basis and Clinical Significance , 1997, European journal of human genetics : EJHG.